Intra-species diversity of Clostridium perfringens: A diverse genetic repertoire reveals its pathogenic potential Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

February 14, 2026

  • Microbes
    Microbes

    Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2026-02-14

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study conducted a large-scale comparative genomic analysis of 372 Clostridium perfringens genomes to evaluate its intra-species genetic diversity, phylogenetic relationships, virulence gene distribution, toxinotypes, and antimicrobial resistance profiles across multiple hosts and environmental sources. The researchers used whole genome sequencing (WGS), multilocus sequence typing (MLST), pangenome analysis, and phylogenetic reconstruction to determine how genomic diversity contributes to microbiome colonization, pathogenic potential, and host adaptation. The analysis identified core and accessory genome components, toxin gene prevalence, clonal complexes, and resistance determinants to better understand how C. perfringens evolves, spreads, and transitions from a commensal microbiome organism to a clinically significant pathogen.

Who was studied?

The study analyzed 372 Clostridium perfringens genomes collected from human stool, animal gastrointestinal microbiomes, food products, environmental sources such as water and soil, and livestock including birds, pigs, horses, and sheep. These isolates originated from multiple countries, with the majority from the United States, France, and China, and included genomes derived from human intestinal microbiomes, foodborne isolates, and environmental reservoirs. The dataset also included newly sequenced isolates from human feces and water, enabling direct assessment of microbiome-associated colonization and environmental transmission patterns across diverse ecological niches and host species.

What were the most important findings?

This study found that Clostridium perfringens possesses extreme genomic diversity driven by a highly plastic genome, with 97.3% of its 35,876 genes classified as accessory and only 2.7% forming the core genome, demonstrating a strong capacity for adaptation, virulence acquisition, and microbiome colonization. Major microbial associations showed that toxinotype A was the most prevalent (53%), followed by toxinotype F (32%) and toxinotype G (7%), with toxinotype F strongly associated with human foodborne illness and gastrointestinal infection. The study identified 195 sequence types grouped into 25 clonal complexes and five phylogenetic groups, demonstrating close genetic relationships between isolates from humans, animals, food, and the environment, confirming zoonotic transmission potential and shared microbiome reservoirs.

Virulence genes were widespread, with plc (alpha toxin), nanH (sialidase), colA (collagenase), and ccp (alpha-clostripain) present in most genomes, supporting microbial adhesion, tissue invasion, immune evasion, and epithelial damage. Additional virulence factors such as perfringolysin O, TpeL toxin, and beta toxin contributed to intestinal barrier disruption and cytotoxicity. The presence of sialidase genes nanH, nanI, and nanJ enhanced bacterial adhesion and microbiome colonization by degrading host glycans and promoting epithelial attachment. Antimicrobial resistance genes were found in 72.8% of genomes, with tetracycline resistance genes tetA and tetB most common, especially in isolates from livestock and food sources, highlighting antimicrobial selection pressure as a major driver of microbiome adaptation and resistance emergence. Phylogenetic analysis confirmed that human, animal, food, and environmental isolates shared closely related genetic lineages, demonstrating widespread microbiome colonization and transmission across ecological niches.

What are the greatest implications of this study?

This study established that Clostridium perfringens is a highly adaptable microbiome-associated pathogen whose extreme genomic plasticity enables rapid acquisition of toxin genes, antimicrobial resistance, and virulence traits, allowing transition from commensal microbiome colonizer to pathogenic organism. The widespread presence of virulence genes, antimicrobial resistance determinants, and shared genetic lineages across human, animal, food, and environmental microbiomes highlights its major role as a zoonotic and foodborne pathogen. These findings emphasize the importance of microbiome surveillance, genomic diagnostics, and antimicrobial stewardship to detect emerging virulent strains and prevent transmission. Understanding the genomic diversity and microbiome-associated virulence mechanisms of C. perfringens will improve risk assessment, clinical diagnosis, and development of microbiome-targeted prevention strategies to reduce gastrointestinal disease burden and limit the spread of antimicrobial resistance.

Clostridium perfringens

Clostridium perfringens is a fast-growing, Gram-positive, spore-forming anaerobe and a major toxin-mediated pathogen affecting humans and animals. Widely distributed in soil, food, and gastrointestinal microbiota, it causes diseases ranging from food poisoning and antibiotic-associated diarrhoea to life-threatening clostridial myonecrosis. Its pathogenicity is driven by diverse plasmid-encoded toxins, including α-toxin, enterotoxin, and perfringolysin O, while conjugative mobile genetic elements facilitate rapid dissemination of antimicrobial resistance and virulence traits. Genome-informed toxinotyping and molecular surveillance are therefore essential for accurate risk assessment, clinical management, and outbreak control.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.